MannKind (MNKD) Stock: Charts & Financials

MannKind Corporation(MNKD)

Biotechnology · Danbury, CA

$3.79-0.03 (-0.73%)

Delayed quote: Oct 6, 2026, 2:35 PM EDT

About MannKind Corporation

MannKind Corporation operates as a biopharmaceutical firm, primarily focused on innovating and bringing to market respiratory-delivered treatments. Its efforts are directed towards tackling endocrine system disorders and rare lung conditions within the U.S. market. The company's key product is Afrezza, an inhaled insulin designed to improve glycemic control for adults managing diabetes. MannKind also actively markets Thyquidity, promoting it to adult and pediatric endocrinologists and other healthcare professionals for the treatment of hypothyroidism. In terms of collaborations, MannKind holds a strategic licensing and partnership agreement with United Therapeutics Corporation. Furthermore, it is collaborating with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), which is a synthetic variant of human vasoactive intestinal peptide intended to shield cells from inflammatory processes. Established in 1991, MannKind Corporation's corporate offices are located in Westlake Village, California.

Danbury, CA

592 employees

www.mannkindcorp.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Michael E. Castagna

View full financials

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Total Current Assets	245.71M	245.71M	251.16M	291.58M	358.84M	279.03M	273.74M	268.31M	327.66M
Cash & Cash Equivalents	52.93M	52.93M	52.83M	74.88M	127.39M	57.01M	47.31M	46.34M	62.37M
Short-Term Investments	58.20M	58.20M	81.03M	96.46M	132.64M	121.98M	134.23M	150.92M	189.22M
Cash & Short-Term Investments	111.13M	111.13M	133.86M	171.35M	260.04M	178.99M	181.54M	197.26M	251.59M
Accounts Receivable	43.21M	43.21M	28.74M	38.37M	18.88M	27.14M	28.90M	11.80M	18.18M
Inventory	44.42M	44.42M	49.17M	35.31M	26.97M	28.49M	28.89M	27.89M	26.66M
Total Assets	732.30M	732.30M	744.40M	792.18M	494.64M	411.70M	410.14M	393.84M	464.20M
Property, Plant & Equipment	85.16M	85.16M	93.84M	82.42M	93.95M	82.97M	83.78M	85.36M	85.34M
Goodwill	67.59M	67.59M	67.59M	67.59M	1.93M	1.93M	1.93M	1.93M	1.93M
Intangible Assets	315.96M	315.96M	320.33M	5.07M	5.12M	5.17M	5.22M	5.26M	5.31M
Long-Term Investments	0.00	0.00	747K	5.01M	26.97M	22.24M	16.68M	5.48M	16.80M
Total Current Liabilities	142.90M	142.90M	134.56M	171.03M	109.13M	111.83M	115.94M	81.84M	72.10M
Accounts Payable	11.04M	11.04M	16.14M	9.03M	7.27M	10.26M	5.04M	6.79M	6.44M
Short-Term Debt	0.00	0.00	12.88M	49.24M	48.95M	36.17M	36.11M	13.12M	0.00
Total Liabilities	799.50M	799.50M	803.60M	843.20M	539.19M	466.74M	468.76M	472.66M	674.13M
Long-Term Debt	319.08M	319.08M	320.73M	320.36M	73.43M	0.00	0.00	38.57M	227.94M
Total Debt	330.85M	330.85M	436.67M	473.38M	225.95M	46.82M	47.25M	157.22M	240.28M
Net Debt (Cash)	277.92M	277.92M	383.84M	398.50M	98.56M	-10.18M	-62K	110.88M	177.91M
Total Shareholders' Equity	-67.20M	-67.20M	-59.20M	-51.02M	-44.55M	-55.04M	-58.62M	-78.82M	-209.93M
Common Stock	3.10M	3.10M	3.09M	3.08M	3.07M	3.06M	3.04M	3.03M	2.75M
Retained Earnings	-3.23B	-3.23B	-3.21B	-3.20B	-3.18B	-3.19B	-3.19B	-3.20B	-3.21B
Current Ratio	1.72	1.72	1.87	1.70	3.29	2.50	2.36	3.28	4.54
Debt to Equity Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Quarterly Report

TTM

Quarter ended Jun 2026

Quarter ended Mar 2026

Quarter ended Dec 2025

Quarter ended Sep 2025

Quarter ended Jun 2025

Quarter ended Mar 2025

Quarter ended Dec 2024

Quarter ended Sep 2024

Total Current Assets

245.71M

251.16M

291.58M

358.84M

279.03M

273.74M

268.31M

327.66M

Cash & Cash Equivalents

52.93M

52.83M

74.88M

127.39M

57.01M

47.31M

46.34M

62.37M

Short-Term Investments

58.20M

81.03M

96.46M

132.64M

121.98M

134.23M

150.92M

189.22M

Cash & Short-Term Investments

111.13M

133.86M

171.35M

260.04M

178.99M

181.54M

197.26M

251.59M

Accounts Receivable

43.21M

28.74M

38.37M

18.88M

27.14M

28.90M

11.80M

18.18M

Inventory

44.42M

49.17M

35.31M

26.97M

28.49M

28.89M

27.89M

26.66M

Total Assets

732.30M

744.40M

792.18M

494.64M

411.70M

410.14M

393.84M

464.20M

Property, Plant & Equipment

85.16M

93.84M

82.42M

93.95M

82.97M

83.78M

85.36M

85.34M

Goodwill

67.59M

1.93M

Intangible Assets

315.96M

320.33M

5.07M

5.12M

5.17M

5.22M

5.26M

5.31M

Long-Term Investments

0.00

747K

5.01M

26.97M

22.24M

16.68M

5.48M

16.80M

Total Current Liabilities

142.90M

134.56M

171.03M

109.13M

111.83M

115.94M

81.84M

72.10M

Accounts Payable

11.04M

16.14M

9.03M

7.27M

10.26M

5.04M

6.79M

6.44M

Short-Term Debt

0.00

12.88M

49.24M

48.95M

36.17M

36.11M

13.12M

0.00

Total Liabilities

799.50M

803.60M

843.20M

539.19M

466.74M

468.76M

472.66M

674.13M

Long-Term Debt

319.08M

320.73M

320.36M

73.43M

0.00

38.57M

227.94M

Total Debt

330.85M

436.67M

473.38M

225.95M

46.82M

47.25M

157.22M

240.28M

Net Debt (Cash)

277.92M

383.84M

398.50M

98.56M

-10.18M

-62K

110.88M

177.91M

Total Shareholders' Equity

-67.20M

-59.20M

-51.02M

-44.55M

-55.04M

-58.62M

-78.82M

-209.93M

Common Stock

3.10M

3.09M

3.08M

3.07M

3.06M

3.04M

3.03M

2.75M

Retained Earnings

-3.23B

-3.21B

-3.20B

-3.18B

-3.19B

-3.20B

-3.21B

Current Ratio

1.72

1.87

1.70

3.29

2.50

2.36

3.28

4.54

Debt to Equity Ratio

N/A

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Current Assets	291.58M	268.31M	373.39M	234.90M	219.49M	79.48M	60.76M	81.85M
Cash & Cash Equivalents	74.88M	46.34M	238.48M	69.77M	124.18M	67.00M	29.91M	71.16M
Short-Term Investments	96.46M	150.92M	56.62M	101.08M	79.93M	0.00	19.98M	0.00
Cash & Short-Term Investments	171.35M	197.26M	295.10M	170.85M	204.12M	67.00M	49.88M	71.16M
Accounts Receivable	38.37M	11.80M	14.90M	16.80M	4.74M	4.22M	3.51M	4.02M
Inventory	35.31M	27.89M	28.55M	21.77M	7.15M	4.97M	4.16M	3.60M
Total Assets	792.18M	393.84M	475.20M	295.28M	321.16M	108.61M	93.72M	107.70M
Property, Plant & Equipment	82.42M	85.36M	84.22M	45.13M	36.61M	25.87M	26.78M	25.60M
Goodwill	67.59M	1.93M	1.93M	2.43M	0.00	0.00	0.00	0.00
Intangible Assets	5.07M	5.26M	1.07M	1.15M	0.00	0.00	0.00	0.00
Long-Term Investments	5.01M	5.48M	7.16M	1.96M	56.62M	0.00	0.00	0.00
Total Current Liabilities	171.03M	81.84M	104.13M	67.30M	48.35M	73.70M	65.62M	75.24M
Accounts Payable	9.03M	6.79M	9.58M	11.05M	6.96M	5.58M	4.79M	5.38M
Short-Term Debt	49.24M	0.00	20.00M	9.56M	6.98M	4.06M	5.03M	11.30M
Total Liabilities	843.20M	472.66M	721.37M	545.82M	530.51M	289.03M	284.25M	282.79M
Long-Term Debt	320.36M	36.05M	248.70M	273.49M	281.20M	118.17M	113.87M	91.19M
Total Debt	473.38M	47.70M	272.62M	288.40M	289.22M	123.44M	121.41M	102.49M
Net Debt (Cash)	398.50M	1.36M	34.14M	218.63M	165.03M	56.43M	91.51M	31.33M
Total Shareholders' Equity	-51.02M	-78.82M	-246.17M	-250.54M	-209.35M	-180.42M	-190.53M	-175.08M
Common Stock	3.08M	3.03M	2.70M	2.64M	2.52M	2.42M	2.12M	1.87M
Retained Earnings	-3.20B	-3.20B	-3.23B	-3.22B	-3.13B	-3.05B	-2.99B	-2.94B
Current Ratio	1.70	3.28	3.59	3.49	4.54	1.08	0.93	1.09
Debt to Equity Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Annual Report

12/31/2025

12/31/2024

12/31/2023

12/31/2022

12/31/2021

12/31/2020

12/31/2019

12/31/2018

Total Current Assets

291.58M

268.31M

373.39M

234.90M

219.49M

79.48M

60.76M

81.85M

Cash & Cash Equivalents

74.88M

46.34M

238.48M

69.77M

124.18M

67.00M

29.91M

71.16M

Short-Term Investments

96.46M

150.92M

56.62M

101.08M

79.93M

0.00

19.98M

0.00

Cash & Short-Term Investments

171.35M

197.26M

295.10M

170.85M

204.12M

67.00M

49.88M

71.16M

Accounts Receivable

38.37M

11.80M

14.90M

16.80M

4.74M

4.22M

3.51M

4.02M

Inventory

35.31M

27.89M

28.55M

21.77M

7.15M

4.97M

4.16M

3.60M

Total Assets

792.18M

393.84M

475.20M

295.28M

321.16M

108.61M

93.72M

107.70M

Property, Plant & Equipment

82.42M

85.36M

84.22M

45.13M

36.61M

25.87M

26.78M

25.60M

Goodwill

67.59M

1.93M

2.43M

0.00

Intangible Assets

5.07M

5.26M

1.07M

1.15M

0.00

Long-Term Investments

5.01M

5.48M

7.16M

1.96M

56.62M

0.00

Total Current Liabilities

171.03M

81.84M

104.13M

67.30M

48.35M

73.70M

65.62M

75.24M

Accounts Payable

9.03M

6.79M

9.58M

11.05M

6.96M

5.58M

4.79M

5.38M

Short-Term Debt

49.24M

0.00

20.00M

9.56M

6.98M

4.06M

5.03M

11.30M

Total Liabilities

843.20M

472.66M

721.37M

545.82M

530.51M

289.03M

284.25M

282.79M

Long-Term Debt

320.36M

36.05M

248.70M

273.49M

281.20M

118.17M

113.87M

91.19M

Total Debt

473.38M

47.70M

272.62M

288.40M

289.22M

123.44M

121.41M

102.49M

Net Debt (Cash)

398.50M

1.36M

34.14M

218.63M

165.03M

56.43M

91.51M

31.33M

Total Shareholders' Equity

-51.02M

-78.82M

-246.17M

-250.54M

-209.35M

-180.42M

-190.53M

-175.08M

Common Stock

3.08M

3.03M

2.70M

2.64M

2.52M

2.42M

2.12M

1.87M

Retained Earnings

-3.20B

-3.23B

-3.22B

-3.13B

-3.05B

-2.99B

-2.94B

Current Ratio

1.70

3.28

3.59

3.49

4.54

1.08

0.93

1.09

Debt to Equity Ratio

N/A

Balance Sheet

Quarterly Balance Sheet (USD)

Annual Balance Sheet (USD)